secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2023-08-28T23:59:59+00:00
Accession:  0001093557-23-000191
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom appoints Rimma Driscoll to Board of Directors; fills audit/tech committee seats
--------------------------------------------------------------------------------

- Rimma Driscoll elected to Board effective August 24, 2023.
- She replaces Nicholas Augustinos on Audit and Technology Committees.
- Ms. Driscoll is EVP at Zoetis, leading global strategy, commercial and business development.
- She received initial RSU grant valued at $500,000 vesting over 3 years.
- Board determined she qualifies as independent under Nasdaq and SEC rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000191/0001093557-23-000191-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355723000191/dxcm-20230824.htm
  HTML page:      https://secwatch.observer/filing/0001093557-23-000191

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer